Zepp Health Gross Margin 2017-2025 | ZEPP
Current and historical gross margin for Zepp Health (ZEPP) over the last 10 years. The current gross profit margin for Zepp Health as of September 30, 2025 is %.
| Zepp Health Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $0.23B | $0.09B | 36.75% |
| 2025-06-30 | $0.20B | $0.07B | 37.00% |
| 2025-03-31 | $0.18B | $0.07B | 37.91% |
| 2024-12-31 | $0.18B | $0.07B | 38.25% |
| 2024-09-30 | $0.21B | $0.08B | 37.38% |
| 2024-06-30 | $0.25B | $0.09B | 35.63% |
| 2024-03-31 | $0.30B | $0.09B | 30.87% |
| 2023-12-31 | $0.35B | $0.09B | 26.14% |
| 2023-09-30 | $0.42B | $0.09B | 22.41% |
| 2023-06-30 | $0.50B | $0.10B | 19.32% |
| 2023-03-31 | $0.58B | $0.11B | 18.61% |
| 2022-12-31 | $0.60B | $0.12B | 19.33% |
| 2022-09-30 | $0.70B | $0.14B | 19.35% |
| 2022-06-30 | $0.82B | $0.17B | 20.32% |
| 2022-03-31 | $0.83B | $0.18B | 21.16% |
| 2021-09-30 | $1.05B | $0.22B | 20.67% |
| 2021-06-30 | $1.13B | $0.24B | 20.80% |
| 2021-03-31 | $1.01B | $0.21B | 20.75% |
| 2020-12-31 | $0.99B | $0.21B | 20.79% |
| 2020-09-30 | $0.95B | $0.21B | 22.26% |
| 2020-06-30 | $0.88B | $0.21B | 23.75% |
| 2020-03-31 | $0.87B | $0.21B | 24.48% |
| 2019-12-31 | $0.84B | $0.21B | 25.15% |
| 2019-09-30 | $0.70B | $0.18B | 25.86% |
| 2019-06-30 | $0.59B | $0.16B | 26.40% |
| 2019-03-31 | $0.56B | $0.15B | 26.31% |
| 2018-12-31 | $0.53B | $0.14B | 25.90% |
| 2018-09-30 | $0.48B | $0.21B | 43.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.402B | $0.183B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.732B | 58.24 |
| Tempus AI (TEM) | United States | $12.524B | 0.00 |
| Doximity (DOCS) | United States | $11.721B | 48.51 |
| Hims & Hers Health (HIMS) | United States | $9.384B | 76.89 |
| IRhythm Technologies (IRTC) | United States | $5.716B | 0.00 |
| Hinge Health (HNGE) | United States | $3.454B | 0.00 |
| Privia Health (PRVA) | United States | $2.943B | 184.46 |
| Heartflow (HTFL) | United States | $2.876B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.435B | 40.29 |
| Enovis (ENOV) | United States | $1.624B | 8.53 |
| 10x Genomics (TXG) | United States | $1.618B | 0.00 |
| Omnicell (OMCL) | United States | $1.605B | 32.81 |
| Schrodinger (SDGR) | United States | $1.373B | 0.00 |
| Azenta (AZTA) | United States | $1.355B | 59.10 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Phreesia (PHR) | United States | $1.334B | 0.00 |
| Claritev (CTEV) | United States | $1.021B | 0.00 |
| Evolent Health (EVH) | United States | $0.705B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.683B | 0.00 |
| Talkspace (TALK) | United States | $0.568B | 113.00 |
| Butterfly Network (BFLY) | United States | $0.566B | 0.00 |
| Veradigm (MDRX) | United States | $0.545B | 0.00 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Carlsmed (CARL) | United States | $0.316B | 0.00 |
| TruBridge (TBRG) | United States | $0.289B | 13.27 |
| CapsoVision (CV) | United States | $0.225B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.220B | 0.00 |
| Outset Medical (OM) | United States | $0.210B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.208B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.186B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.183B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.171B | 0.00 |
| CareCloud (CCLD) | United States | $0.147B | 8.07 |
| EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.074B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.037B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |